Cargando…
Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin
Despite recent advances in treatment, cancer continues to be one of the most lethal human maladies. One of the challenges of cancer treatment is the diversity among similar tumors that exhibit different clinical outcomes. Most of this variability comes from wide-spread molecular alterations that can...
Autores principales: | González-Reymúndez, Agustín, Vázquez, Ana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239905/ https://www.ncbi.nlm.nih.gov/pubmed/32433524 http://dx.doi.org/10.1038/s41598-020-65119-5 |
Ejemplares similares
-
MOSS: multi-omic integration with sparse value decomposition
por: Gonzalez-Reymundez, Agustin, et al.
Publicado: (2022) -
Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions
por: González-Reymúndez, Agustín, et al.
Publicado: (2017) -
Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme
por: Bernal Rubio, Yeni L., et al.
Publicado: (2018) -
Biomarker signature identification in “omics” data with multi-class outcome
por: Lagani, Vincenzo, et al.
Publicado: (2013) -
Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
por: Jiao, Zonglin, et al.
Publicado: (2022)